BioCentury
ARTICLE | Company News

AdProTech, Inflazyme deal

April 26, 2004 7:00 AM UTC

IZP completed its previously announced acquisition of Adprotech for 12.7 million shares, valued at C$18.4 million (US$13.7 million) using IZP's pre-deal closing price of C$1.45 on April 20. The deal w...